1FDA. The prescriptions drug abuse epideMic: how prescription Monitoring prograMs can help[EB/OL], http://www, fda. gov/ downloads/Drugs/News Events/UCM234188. pdf, 2010-11-16. 2012-01-21.
2Deborah B. LeiderMan. Risk ManageMent and the controlled sub stances act: the FDA perspective [ EB/OL]. http://www. {da. gov/ohrMs/dockets/ac/O3/slides/3978S1 02 LeiderMan. ppt. 2003-09-09. 2012-01-21.
3Karen BluMenschein,Joseph L. Fink III, Patricia R Free-Man, et al. Review of prescription drug Monitoring pro-graMs in the U- nited States [EB/OL]. http//ehfs, ky. gov/NR/rdonlyres/ 85989824-1030-4AA6-91E1-TF9E3EF68827/0/KASPERE valua- tion PDMP Status Final Report 6242010. pdL 2010-06. 2012-01- 21.
4FDA. FDA regulation processes and standards for review and ap- proval of opioid anaigesics an educational priMer and conversa- tion [ EB/OL]. http://www, fda. gov/downloads/Drugs/Drug Safety/InforMation by Drug Clash. UCM163691. pdf. 2009v02- 10. 2012-01-21.
